Suppr超能文献

基于人群的队列中炎症标志物的长期变异性及其相关因素。

Long-term variability of inflammatory markers and associated factors in a population-based cohort.

机构信息

Department of Population Health Sciences, University of Wisconsin, Madison, Wisconsin 53726, USA.

出版信息

J Am Geriatr Soc. 2013 Aug;61(8):1269-76. doi: 10.1111/jgs.12382. Epub 2013 Jul 26.

Abstract

OBJECTIVES

To investigate long-term variability in serum high-sensitivity C-reactive protein (CRP) and interleukin-6 (IL-6) and to determine associated risk factors for high-risk inflammatory profiles.

DESIGN

Prospective population-based cohort study.

PARTICIPANTS

Participants (N = 1,443) of the Epidemiology of Hearing Loss Study and the Beaver Dam Eye Study, two population-based prospective studies of aging in the same cohort.

MEASUREMENTS

In participants aged 43 to 79 at the initial examination (1988-1990), serum high-sensitivity CRP was measured from three time-points (1988-1990, 1998-2000, 2009-2010), and serum IL-6 was measured from two (1998-2000, 2009-2010).

RESULTS

When IL-6 levels were categorized into tertiles, 50.8% of participants were in the same group 10 years later (weighted kappa (κ) = 0.34). When CRP was categorized into three risk groups, 53.4% of participants were in the same group 10 years later (κ = 0.36), and 32.4% were in the same group at all three examinations (κ = 0.27). IL-6 increased from a geometric mean of 1.54 pg/L to 1.78 pg/L over 10 years, whereas CRP increased from a geometric mean of 1.67 mg/L to 2.25 mg/L over 10 years and then decreased to 1.93 mg/L over the next 10 years. These 10-year decreases in CRP were not observed in those not reporting statin use. Factors associated with long-term higher levels of IL-6 and CRP were older age (IL-6), obesity, smoking, lower physical activity (IL-6), lower high-density lipoprotein cholesterol (IL-6), and a history of statin (non)use (CRP).

CONCLUSION

Inflammatory marker levels tracked over the long term into older age with within-person increases were observed. Several potentially modifiable risk factors were associated with long-term higher levels of inflammatory markers.

摘要

目的

研究血清高敏 C 反应蛋白(CRP)和白细胞介素 6(IL-6)的长期变化,并确定高危炎症谱的相关危险因素。

设计

前瞻性人群为基础的队列研究。

参与者

流行病学听力损失研究和比弗大坝眼研究的参与者(N=1443),这是同一队列中两项老龄化的人群为基础的前瞻性研究。

测量

在初次检查时(1988-1990 年)年龄为 43 至 79 岁的参与者中,分别在三个时间点(1988-1990 年、1998-2000 年、2009-2010 年)测量血清高敏 CRP,并且在两个时间点(1998-2000 年、2009-2010 年)测量血清 IL-6。

结果

当将 IL-6 水平分为三分位时,10 年后 50.8%的参与者处于同一组(加权 κ(κ)=0.34)。当 CRP 分为三组风险组时,10 年后 53.4%的参与者处于同一组(κ=0.36),并且 32.4%的参与者在所有三个检查中处于同一组(κ=0.27)。10 年内,IL-6 从 1.54pg/L 的几何均数增加到 1.78pg/L,而 CRP 从 1.67mg/L 的几何均数增加到 2.25mg/L,然后在接下来的 10 年内下降到 1.93mg/L。在未报告使用他汀类药物的人群中未观察到 CRP 的这种 10 年下降。与长期较高水平的 IL-6 和 CRP 相关的因素是年龄较大(IL-6)、肥胖、吸烟、较低的体力活动(IL-6)、较低的高密度脂蛋白胆固醇(IL-6)和他汀类药物(非)使用史(CRP)。

结论

观察到炎症标志物水平在长期内跟踪到老年,并且个体内的增加。一些潜在的可改变的危险因素与长期较高水平的炎症标志物有关。

相似文献

1
Long-term variability of inflammatory markers and associated factors in a population-based cohort.
J Am Geriatr Soc. 2013 Aug;61(8):1269-76. doi: 10.1111/jgs.12382. Epub 2013 Jul 26.
2
Long-term systemic inflammation and cognitive impairment in a population-based cohort.
J Am Geriatr Soc. 2014 Sep;62(9):1683-91. doi: 10.1111/jgs.12994. Epub 2014 Aug 14.
3
Inflammatory and vascular markers and olfactory impairment in older adults.
Age Ageing. 2015 Sep;44(5):878-82. doi: 10.1093/ageing/afv075. Epub 2015 Jun 16.
4
The prevalence and predictors of elevated C-reactive protein after a coronary heart disease event.
Eur J Prev Cardiol. 2018 Jun;25(9):923-931. doi: 10.1177/2047487318768940. Epub 2018 Apr 11.
9
Long-term assessment of inflammation and healthy aging in late life: the Cardiovascular Health Study All Stars.
J Gerontol A Biol Sci Med Sci. 2012 Sep;67(9):970-6. doi: 10.1093/gerona/glr261. Epub 2012 Feb 24.
10
Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes.
Heart. 2017 Nov;103(22):1821-1829. doi: 10.1136/heartjnl-2016-311079. Epub 2017 May 10.

引用本文的文献

1
Association of Hearing Loss and Eating Habits in the Older Population.
Am J Lifestyle Med. 2023 Dec 1;19(3):361-367. doi: 10.1177/15598276231216392. eCollection 2025 Mar-Apr.
2
Low-Dose Aspirin and Progression of Age-Related Hearing Loss: A Secondary Analysis of the ASPREE Randomized Clinical Trial.
JAMA Netw Open. 2024 Jul 1;7(7):e2424373. doi: 10.1001/jamanetworkopen.2024.24373.
4
Revascularization of Peripheral Arteries in Patients with Intermittent Claudication Decreases Inflammatory Biomarkers.
Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231176815. doi: 10.1177/10760296231176815.
5
A systematic review and meta-analysis of the stability of peripheral immune markers in healthy adults.
Brain Behav Immun. 2023 Jan;107:32-46. doi: 10.1016/j.bbi.2022.09.011. Epub 2022 Sep 21.
6
Pharmacotherapeutic approach toward urological medications and vaccination during COVID-19: a narrative review.
Ther Adv Urol. 2021 Sep 28;13:17562872211046794. doi: 10.1177/17562872211046794. eCollection 2021 Jan-Dec.
7
Testosterone in COVID-19 - Foe, Friend or Fatal Victim?
Eur Endocrinol. 2020 Oct;16(2):88-91. doi: 10.17925/EE.2020.16.2.88. Epub 2020 Oct 6.
9
Cytokines for evaluation of chronic inflammatory status in ageing research: reliability and phenotypic characterisation.
Immun Ageing. 2019 May 21;16:11. doi: 10.1186/s12979-019-0151-1. eCollection 2019.
10
An Epidemiologic Study of the Association between Free Recall Dichotic Digits Test Performance and Vascular Health.
J Am Acad Audiol. 2019 Apr;30(4):282-292. doi: 10.3766/jaaa.17079. Epub 2018 Feb 13.

本文引用的文献

2
Long-term assessment of inflammation and healthy aging in late life: the Cardiovascular Health Study All Stars.
J Gerontol A Biol Sci Med Sci. 2012 Sep;67(9):970-6. doi: 10.1093/gerona/glr261. Epub 2012 Feb 24.
4
Association of statins with inflammatory cytokines: a population-based Colaus study.
Atherosclerosis. 2011 Nov;219(1):253-8. doi: 10.1016/j.atherosclerosis.2011.07.117. Epub 2011 Aug 4.
6
Inflammatory markers in population studies of aging.
Ageing Res Rev. 2011 Jul;10(3):319-29. doi: 10.1016/j.arr.2010.11.002. Epub 2010 Dec 8.
7
Effects of statins on serum inflammatory markers: the U.S. National Health and Nutrition Examination Survey 1999-2004.
J Atheroscler Thromb. 2010 Nov 27;17(11):1176-82. doi: 10.5551/jat.5652. Epub 2010 Aug 25.
8
C-reactive protein lowering with rosuvastatin in the METEOR study.
J Intern Med. 2010 Aug;268(2):155-61. doi: 10.1111/j.1365-2796.2010.02230.x. Epub 2010 Mar 6.
9
A unifying biologic explanation for "high-sensitivity" C-reactive protein and "low-grade" inflammation.
Arthritis Care Res (Hoboken). 2010 Apr;62(4):442-6. doi: 10.1002/acr.20052.
10
Predictors of C-reactive protein in the national social life, health, and aging project.
J Gerontol B Psychol Sci Soc Sci. 2011 Jan;66(1):129-36. doi: 10.1093/geronb/gbq008. Epub 2010 Feb 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验